KLOW is the four-peptide blend that’s quietly become the default healing stack on the underground peptide circuit. Four compounds in a single vial, one injection a day. The name is just the first letters: K-L-O-W. The pitch is convenience: one shot, four mechanisms.
Most people don’t realize what’s in KLOWuntil they read the label closely. Here’s what each of the four components does, why they’re paired, and whether the blend actually beats running them separately.
The four peptides
KPV(Lys-Pro-Val) is a tripeptide fragment of alpha-MSH. Its main job in KLOW is anti-inflammatory — it shuts down NF-kB signaling and damps systemic inflammation. Useful on its own for gut issues, autoimmune flares, and chronic inflammation that won’t quit.
GHK-Cuis a copper-binding tripeptide best known for skin and hair, but its real superpower in a healing stack is collagen synthesis. It tells fibroblasts to make more extracellular matrix — the stuff that holds wounds together. Also responsible for KLOW’s distinctive blue color when reconstituted.
BPC-157— the famous one. Body Protective Compound 157 promotes angiogenesis (new blood vessel formation at injury sites) and modulates nitric oxide signaling. It’s the workhorse of soft-tissue healing in animal studies. In KLOW it does the heaviest lifting on tendon and ligament recovery.
TB-500 is a synthetic fragment of thymosin beta-4. It works by sequestering actin, which lets cells migrate freely to wherever needs repair. The systemic regeneration peptide — the same dose hits muscle, tendon, nerve, and skin.
Why the blend?
The mechanisms stack cleanly. KPV reduces the inflammation that’s slowing recovery. GHK-Cu builds new collagen for structural repair. BPC-157 brings blood supply and signaling. TB-500 mobilizes cells to migrate to the injury site. Different jobs, complementary outputs.
The convenience matters too. Run these four separately and you’re doing 25+ injections a week to keep daily protocols on each (BPC-157 daily, TB-500 2–3×/week, KPV daily, GHK-Cu 5×/week). With KLOW, it’s seven injections. Same mechanisms, less micromanagement.
The math
Standard KLOW vial: 80 mg total in 2 mL of bacteriostatic water = 40 mg/mL working solution. The 80 mg is roughly 20 mg of each compound — though ratios vary by vendor. Check the COA, not the marketing page.
Typical dose: 5 mg per shot, daily. That’s 5 ÷ 40 = 0.125 mL = 12.5 units on a U-100 insulin syringe. Each shot delivers approximately 1.25 mg of each component — a meaningful dose for BPC-157 and TB-500 individually.
For the math on your specific vial, use the KLOW reconstitution calculator. For non-standard ratios (some vendors do 100 mg vials, some 60 mg) the per-shot composition shifts.
When KLOW beats running peptides separately
For general recovery from training, post-surgery healing, or chronic low-level inflammation — KLOW is the easier protocol and the results are largely indistinguishable from running the four separately at standard doses. Most people who try it stop running the individual peptides.
For specific injury protocols (loading-phase TB-500 at 5–10 mg/week for an acute injury), running TB-500 alone at the loading dose is the better move. KLOW gives you maintenance-dose TB-500, not loading-dose.
For severe gut issues where KPV is the lead actor, running KPV solo at 250–500 mcg lets you titrate independently. KLOW gives you a fixed ratio.
Stacking notes
KLOW + GH peptides (ipamorelin, CJC-1295, sermorelin) is a common protocol — the healing peptides handle structural repair; the GH peptides handle regenerative signaling. Different mechanisms, no interaction concerns.
KLOW + Tesamorelin pairs well for older lifters managing both injury recovery and visceral fat. The two stacks operate on completely separate axes.
KLOW + Tirzepatide or Retatrutide: works fine, but the GLP-1 family will dominate the nausea and appetite space. Run the KLOW separately in the day and the GLP-1 once a week.
The honest caveats
- Vendor ratios vary. An 80 mg KLOW from vendor A is not the same as an 80 mg KLOW from vendor B. Check the COA for the per-compound mg breakdown.
- Cancer caveat applies. BPC-157 and TB-500 in the blend can theoretically accelerate growth of existing tumors via the angiogenesis and tissue-regeneration pathways. KLOW carries the same warning as the components.
- Fixed ratio = no independent dialing. If you need to dose one compound up without overshooting the others, run them separately.
- Post-injection pain is real. The GHK-Cu component is responsible — described as comparable to injecting Winstrol, lasting a few hours. It’s the most commonly reported side effect. Tolerable for most; start with low volume injections to calibrate.
- Supplement with zinc. GHK-Cu is 18.7% copper by molecular weight. At practical doses you’re well inside the safe range, but copper does displace zinc. Run 25 mg zinc picolinate year-round while using KLOW. Women with copper IUDs carry an additional copper load and should factor that in.
- The blue color is real. If reconstituted KLOW isn’t deep blue, the GHK-Cu component is off — either the powder didn’t dissolve or the vial is bad.
Where to buy
NovaPeptidesells an 80 mg KLOW vial that ships with a third-party COA on every batch. The per-compound ratio is published — which most vendors don’t bother to do. Use the BIOHACKMAXX code at checkout for 15% off.
Bottom line
KLOW is convenience plus complementary mechanisms. For general healing, post-training recovery, and chronic inflammation, it’s the easier-to-run version of the four-peptide healing stack. For injury-specific loading protocols, run TB-500 or BPC-157 individually at their loading doses. Both approaches work — KLOW is just the lower-friction one.
For the math, use the KLOW calculator. For the full protocols on each component, the free Peptide Guide breaks down each peptide independently.